Since the current understanding of the precise molecular mechanisms of these mutations is limited, there is no efficient method to treat their associated mitochondrial diseases.
The current lack of knowledge about the molecular mechanisms behind these mutations hinders the development of effective treatments for associated mitochondrial diseases.